Abstract
Dermatomyositis is a multisystem disease manifesting as an idiopathic inflammatory myopathy, characterised predominantly by cutaneous and muscular abnormalities. Patients with dermatomyositis display characteristic skin changes in addition to muscle weakness. Many consider dermatomyositis a paraneoplastic syndrome, as up to 32% of patients with dermatomyositis will develop cancer. Discussed here is the case of a 69-year-old man with a new diagnosis of dermatomyositis who was referred to a tertiary institution with an 8-month history of rash, proximal muscle weakness, fatigue and weight loss. In the absence of clinical symptoms, negative cancer markers and a negative CT chest, abdomen and pelvis, positron emission tomography–CT prompted a gastroscopy, which led to the discovery of a stage T1b oesophageal adenocarcinoma. The oesophageal adenocarcinoma was treated with a gastrointestinal endoscopic mucosal resection and subsequent oesophajectomy. The patient’s dermatomyositis was treated successfully with oral prednisolone and methotrexate.
Reference20 articles.
1. Dermatomyositis/polymyositis and anti-TNF-α therapies: a literature review;Brunasso;Expert Rev Dermatol,2013
2. Mantegazza R
,
Bernasconi P
. Inflammatory Myopathies: Dermatomyositis, Polymyositis and Inclusion Body Myositis. 2013.
3. The treatment and prognosis of dermatomyositis: an updated review;Iorizzo;J Am Acad Dermatol,2008
4. Epidemiology and estimated population burden of selected autoimmune diseases in the United States;Jacobson;Clin Immunol Immunopathol,1997
5. Dermatopolymyositis and other connective tissue diseases: a review of 105 cases;Tymms;J Rheumatol,1985
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献